Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,865 | -2,423 | -1,439 | -8,914 | -6,149 |
| Depreciation Amortization | 11 | 7 | 4 | 296 | 276 |
| Accounts receivable | N/A | N/A | N/A | 222 | 224 |
| Accounts payable and accrued liabilities | 78 | 71 | 111 | 518 | 25 |
| Other Working Capital | 138 | 148 | 587 | 1,593 | 464 |
| Other Operating Activity | 1,206 | 486 | 420 | 260 | -298 |
| Operating Cash Flow | $-2,433 | $-1,711 | $-317 | $-6,025 | $-5,458 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -23 | -28 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-23 | $-28 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,482 | 2,408 | 458 | 3,743 | 3,743 |
| Financing Cash Flow | $2,482 | $2,408 | $458 | $3,743 | $3,743 |
| Beginning Cash Position | 23 | 23 | 23 | 2,328 | 2,328 |
| End Cash Position | 72 | 719 | 164 | 23 | 585 |
| Net Cash Flow | $49 | $697 | $141 | $-2,306 | $-1,743 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,433 | -1,711 | -317 | -6,025 | -5,458 |
| Capital Expenditure | N/A | N/A | N/A | -23 | -28 |
| Free Cash Flow | -2,433 | -1,711 | -317 | -6,049 | -5,486 |